China Stocks break 4-day winning streak, regulatory concerns linger

Last Updated : May 19 2017 | 12:02 AM IST

The Mainland China equity market closed higher down for the first time in five straight sessions on Wednesday, 17 May 2017, as investors opted to book gain off the table amid lingering concerns over tighter regulation and economic growth despite recent soothing regulatory comments. Most sectors lost ground, led by defensive consumer and healthcare stocks, as investors took profits from the recent rally. The blue-chip CSI300 index fell 0.5%, to 3,409.97 points, while the Shanghai Composite Index lost 0.3% to 3,104.44 points.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Already subscribed? Log in

Subscribe to read the full story →

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

In-depth market analysis & insights with access to The Smart Investor

Ad-free Reading

Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

Access Business Standard across devices — mobile, tablet, or PC, via web or app

SAVE 25%

Subscribe for ₹2,700 / 1 Year

Connect with us on WhatsApp

China Stocks break 4-day winning streak, regulatory concerns linger